Analog Device, Inc.
10
3
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
10.0%
1 terminated/withdrawn out of 10 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
75%
3 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Role: lead
Proximal Risk for Suicide in Adolescents
Role: collaborator
Post-Operative Physical Activity Monitoring: Algorithm Performance and Clinical Outcomes
Role: collaborator
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
Role: lead
Clinical Validation Study for CPM Device
Role: lead
Respiration Validation for CPM Device
Role: lead
Study of ADI CardioPulmonary Management (CPM) System
Role: lead
Assessment of Heart Failure (HF) At-Home Management Solution ADI Cardio Pulmonary Monitoring System (CPM)
Role: lead
Clinical Data Collection Study Using CPM System
Role: lead
ECG Validation Study
Role: lead
All 10 trials loaded